Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126952051 | 12695205 | 1 | I | 201603 | 20160818 | 20160829 | 20160829 | EXP | US-SA-2016SA154068 | AVENTIS | 65.00 | YR | E | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126952051 | 12695205 | 1 | PS | LANTUS SOLOSTAR | INSULIN GLARGINE | 1 | Unknown | DOSE:80 UNIT(S) | 6F3178A | 21081 | QD | ||||||||
| 126952051 | 12695205 | 2 | C | SOLOSTAR | DEVICE | 1 | DOSE:80 UNIT(S) | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126952051 | 12695205 | 1 | Type 2 diabetes mellitus |
| 126952051 | 12695205 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126952051 | 12695205 | OT |
| 126952051 | 12695205 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126952051 | 12695205 | Agitation | |
| 126952051 | 12695205 | Cataract | |
| 126952051 | 12695205 | Hepatic cancer | |
| 126952051 | 12695205 | Pancreatic carcinoma | |
| 126952051 | 12695205 | Thrombosis | |
| 126952051 | 12695205 | Visual impairment | |
| 126952051 | 12695205 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |